Dr. Jose A Guzman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 21 W Clarke Ave, Milford, DE 19963 Phone: 302-422-4047 Fax: 402-424-0844 |
Dr. Phong Quoc Le, D.O. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1197 Airport Rd, Milford, DE 19963 Phone: 844-365-7246 |
Dr. Walter Brian Moore, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 21 W Clarke Ave, Milford, DE 19963 Phone: 302-422-4047 Fax: 302-424-0844 |
News Archive
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present at the Cell & Gene Therapy Forum 2015, January 26 - 28, 2015 at Grand Hayatt in Washington DC, United States.
Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic Delayed-release Tablets.
A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.
› Verified 9 days ago